KPV
Emerging Research
KPV is a small anti-inflammatory peptide derived from a natural hormone called alpha-MSH. This peptide has strong anti-inflammatory and antimicrobial properties without the pigmentation effects of full α-MSH. KPV has shown particular promise for inflammatory bowel diseases, skin conditions, and immune modulation through its ability to penetrate cells and interact directly with inflammatory signaling pathways.
How it works
Enters cells and inhibits inflammatory pathways at the nuclear level, particularly NF-κB (a key inflammation switch) signaling
Key benefits
- ✓Systemic anti-inflammatory effects
- ✓immune modulation
- ✓potential for autoimmune conditions
Related goals
Injection
recommendedThe primary route for whole-body anti-inflammatory and immune-modulating effects. KPV injection delivers the peptide systemically for conditions affecting multiple areas, autoimmune support, and broad inflammation reduction.
Injection protocols
| Protocol | Dose | Frequency |
|---|---|---|
| General anti-inflammatory | 200-300mcg | Once daily |
| Active inflammation | 250mcg | Twice daily |
| Autoimmune support | 500mcg | Once daily |
| Acute flare-ups | 500mcg | Twice daily for 1 week, then reduce |
Protocols are from published research literature. This is not medical advice. Dosing should be determined by a licensed clinician.
What to expect
Noticeable decrease in inflammatory symptoms.
Reduced pain and swelling, improved energy.
Significant improvement in target condition.
Sustained anti-inflammatory benefits.
What to know
- ⚠Excellent safety profile with minimal side effects
- ⚠Does not cause immunosuppression like steroids
- ⚠No melanin production or tanning effects
- ⚠Monitor for signs of infection (rare)
- ⚠Generally well-tolerated even at higher doses
Also available as
Gut inflammation and IBD/IBS
Oral KPV delivers the peptide directly to the gastrointestinal tract, making it the preferred route for inflammatory bowel disease, IBS, and gut-specific inflammation. Three distinct protocols address different levels of gut inflammation severity.
Full details →TopicalSkin conditions and psoriasis
Topical KPV targets skin inflammation directly. Research shows topical KPV reduced psoriatic markers by 60%. Best for psoriasis, eczema, and localized skin inflammation where systemic treatment is not needed.
Full details →Nasal sprayChronic sinusitis relief
Nasal KPV delivers anti-inflammatory action directly to the sinus passages for chronic sinusitis and nasal inflammation. Targets the source of sinus inflammation without systemic exposure.
Full details →